Clinical Trial Update: SUBLIVAC FIX Phleum Pratense DT/DRF [Phase 2]

View source ↗

Summary

Phase 2 trial of SUBLIVAC FIX Phleum Pratense DT/DRF has completed, evaluating its use for allergic rhinitis and allergic rhinoconjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinoconjunctivitis

Drugs mentioned

• SUBLIVAC FIX Phleum Pratense DT/DRF (Phleum pratense allergoid)

Snippet

Sponsor: HAL Allergy | Conditions: Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 2 | Status: COMPLETED